204 related articles for article (PubMed ID: 36769068)
21. Prognostic Significance of the Tumor-Stromal Ratio in Invasive Breast Cancer and a Proposal of a New Ts-TNM Staging System.
Xu Q; Yuan JP; Chen YY; Zhang HY; Wang LW; Xiong B
J Oncol; 2020; 2020():9050631. PubMed ID: 32377197
[TBL] [Abstract][Full Text] [Related]
22. Tumor-stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation.
Lv Z; Cai X; Weng X; Xiao H; Du C; Cheng J; Zhou L; Xie H; Sun K; Wu J; Zheng S
Surgery; 2015 Jul; 158(1):142-50. PubMed ID: 25890776
[TBL] [Abstract][Full Text] [Related]
23. Addition of the tumour-stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma.
Mascitti M; Zhurakivska K; Togni L; Caponio VCA; Almangush A; Balercia P; Balercia A; Rubini C; Lo Muzio L; Santarelli A; Troiano G
Histopathology; 2020 Nov; 77(5):810-822. PubMed ID: 32633006
[TBL] [Abstract][Full Text] [Related]
24. Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides.
Woerl AC; Eckstein M; Geiger J; Wagner DC; Daher T; Stenzel P; Fernandez A; Hartmann A; Wand M; Roth W; Foersch S
Eur Urol; 2020 Aug; 78(2):256-264. PubMed ID: 32354610
[TBL] [Abstract][Full Text] [Related]
25. e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study.
Smit MA; van Pelt GW; Dequeker EM; Al Dieri R; Tollenaar RA; van Krieken JHJ; Mesker WE;
JMIR Form Res; 2021 Mar; 5(3):e19408. PubMed ID: 33739293
[TBL] [Abstract][Full Text] [Related]
26. Whole-Slide Image Analysis Reveals Quantitative Landscape of Tumor-Immune Microenvironment in Colorectal Cancers.
Yoo SY; Park HE; Kim JH; Wen X; Jeong S; Cho NY; Gwon HG; Kim K; Lee HS; Jeong SY; Park KJ; Han SW; Kim TY; Bae JM; Kang GH
Clin Cancer Res; 2020 Feb; 26(4):870-881. PubMed ID: 31757879
[TBL] [Abstract][Full Text] [Related]
27. Tumor-stroma ratio (TSR) in non-small cell lung cancer (NSCLC) patients after lung resection is a prognostic factor for survival.
Xi KX; Wen YS; Zhu CM; Yu XY; Qin RQ; Zhang XW; Lin YB; Rong TH; Wang WD; Chen YQ; Zhang LJ
J Thorac Dis; 2017 Oct; 9(10):4017-4026. PubMed ID: 29268412
[TBL] [Abstract][Full Text] [Related]
28. Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma.
Liu J; Liu J; Li J; Chen Y; Guan X; Wu X; Hao C; Sun Y; Wang Y; Wang X
Gynecol Oncol; 2014 Jan; 132(1):81-6. PubMed ID: 24219981
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer.
Peng YL; Wu ZS; Lu HM; Wei WS; Xiong LB; Yu CP; Liu ZF; Li XD; Jiang LJ; Li YH; Liu ZW; Zhang ZL; Zhou FJ
Am J Transl Res; 2020; 12(10):6524-6536. PubMed ID: 33194049
[TBL] [Abstract][Full Text] [Related]
30. Uniform Noting for International Application of the Tumor-Stroma Ratio as an Easy Diagnostic Tool: Protocol for a Multicenter Prospective Cohort Study.
Smit M; van Pelt G; Roodvoets A; Meershoek-Klein Kranenbarg E; Putter H; Tollenaar R; van Krieken JH; Mesker W
JMIR Res Protoc; 2019 Jun; 8(6):e13464. PubMed ID: 31199317
[TBL] [Abstract][Full Text] [Related]
31. The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients.
Vangangelt KMH; Tollenaar LSA; van Pelt GW; de Kruijf EM; Dekker TJA; Kuppen PJK; Tollenaar RAEM; Mesker WE
Int J Cancer; 2018 Dec; 143(12):3194-3200. PubMed ID: 29978463
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
[TBL] [Abstract][Full Text] [Related]
33. A TP53-based immune prognostic model for muscle-invasive bladder cancer.
Li H; Lu H; Cui W; Huang Y; Jin X
Aging (Albany NY); 2020 Dec; 13(2):1929-1946. PubMed ID: 33323544
[TBL] [Abstract][Full Text] [Related]
34. A computed tomography-based multitask deep learning model for predicting tumour stroma ratio and treatment outcomes in patients with colorectal cancer: a multicentre cohort study.
Cui Y; Zhao K; Meng X; Mao Y; Han C; Shi Z; Yang X; Tong T; Wu L; Liu Z
Int J Surg; 2024 May; 110(5):2845-2854. PubMed ID: 38348900
[TBL] [Abstract][Full Text] [Related]
35. Assessment of Immunological Features in Muscle-Invasive Bladder Cancer Prognosis Using Ensemble Learning.
Gavriel CG; Dimitriou N; Brieu N; Nearchou IP; Arandjelović O; Schmidt G; Harrison DJ; Caie PD
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33915698
[TBL] [Abstract][Full Text] [Related]
36. Identifying Potential Prognostic Markers for Muscle-Invasive Bladder Urothelial Carcinoma by Weighted Gene Co-Expression Network Analysis.
Feng Y; Jiang Y; Wen T; Meng F; Shu X
Pathol Oncol Res; 2020 Apr; 26(2):1063-1072. PubMed ID: 31011911
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value of the tumor-stroma ratio in squamous cell lung cancer, a cohort study.
Smit MA; Philipsen MW; Postmus PE; Putter H; Tollenaar RA; Cohen D; Mesker WE
Cancer Treat Res Commun; 2020; 25():100247. PubMed ID: 33249210
[TBL] [Abstract][Full Text] [Related]
38. Triple-marker immunohistochemical assessment of muscle-invasive bladder cancer: Is there prognostic significance?
Labban M; Najdi J; Mukherji D; Abou-Kheir W; Tabbarah A; El-Hajj A
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1313. PubMed ID: 33538412
[TBL] [Abstract][Full Text] [Related]
39. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS
Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
[TBL] [Abstract][Full Text] [Related]
40. Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer.
Abudurexiti M; Xie H; Jia Z; Zhu Y; Zhu Y; Shi G; Zhang H; Dai B; Wan F; Shen Y; Ye D
Front Oncol; 2019; 9():856. PubMed ID: 31552180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]